Facebook
Messenger
Twitter
LinkedIn
Email
Print
Mayo Researchers Explore Genetics Behind COVID-19 Outcomes
Share this:
Some patients with COVID-19 experience severe complications, such as organ damage, shortness of breath, neurological impairment and chronic fatigue. A team of researchers within Mayo Clinic Center for Individualized Medicine is contributing to the global effort of using advanced genetic sequencing to find out which genes influence disease outcomes.
“Our findings will be crucial in treating and caring for COVID-19 survivors, as well as to try to prevent lingering complications in newly infected people,” says Konstantinos Lazaridis, M.D., the Everett J. and Jane M. Hauck associate director of Mayo Clinic Center for Individualized Medicine.
Dr. Lazaridis and his team are building a library of genomic sequencing data of consented patients who tested positive for COVID-19. Learn more about Dr. Lazaridis' work at the Center for Individualized Medicine.
Make a gift now to help transform the future of health care today.
Ann Arneson describes her journey to Mayo Clinic as “divine design.” Ann — a retired teacher, a leader in her church and ministry, mother, grandmother, and line dance enthusiast — is Mayo Clinic’s first bone marrow transplant patient to recover at home thanks to the new advanced care at home program.
Darcy Reed's Mayo Clinic journey started 25 years ago, and she remembers well the first time she walked through the door as a student at Mayo Clinic Alix School of Medicine.
Shannon T.N. Coombs has faced her share of adversity well before this year. So, managing — and thriving as a medical student — through a global pandemic is just another step toward her ultimate goal.